Rubiato, Gyne Kurl .
HRN: 21-07-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/18/2026
CEFUROXIME 500MG (TAB)
04/19/2026
04/26/2026
PO
1 Tab
BID
SP NSD W RMLE; RBOW
Pending Pharmacy Acceptance
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: